These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20796250)

  • 1. The R30Q DLG5 variant is not associated with celiac disease or inflammatory bowel disease in the Spanish population.
    Dema B; Fernández-Arquero M; Maluenda C; Polanco I; Figueredo MA; De La Concha EG; Urcelay E; Núñez C
    Tissue Antigens; 2011 Jan; 77(1):62-4. PubMed ID: 20796250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DLG5 variants in inflammatory bowel disease.
    Büning C; Geerdts L; Fiedler T; Gentz E; Pitre G; Reuter W; Luck W; Buhner S; Molnar T; Nagy F; Lonovics J; Dignass A; Landt O; Nickel R; Genschel J; Lochs H; Schmidt HH; Witt H
    Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease.
    Biank V; Friedrichs F; Babusukumar U; Wang T; Stoll M; Broeckel U; Kugathasan S
    Am J Gastroenterol; 2007 Feb; 102(2):391-8. PubMed ID: 17156146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in DLG5 is associated with inflammatory bowel disease.
    Stoll M; Corneliussen B; Costello CM; Waetzig GH; Mellgard B; Koch WA; Rosenstiel P; Albrecht M; Croucher PJ; Seegert D; Nikolaus S; Hampe J; Lengauer T; Pierrou S; Foelsch UR; Mathew CG; Lagerstrom-Fermer M; Schreiber S
    Nat Genet; 2004 May; 36(5):476-80. PubMed ID: 15107852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DLG5 P1371Q is associated with inflammatory bowel disease and complementary to R30Q in disease susceptibility.
    Lin Z; Hegarty JP; Berb A; Wang Z; Kelly AA; Wang Y; Poritz LS; Wu R; Koltun WA
    Swiss Med Wkly; 2011; 141():w13290. PubMed ID: 22065243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population.
    Pearce AV; Fisher SA; Prescott NJ; Onnie CM; Pattni R; Green P; Forbes A; Mansfield J; Sanderson J; Schreiber S; Lewis CM; Mathew CG
    Int J Colorectal Dis; 2007 Apr; 22(4):419-24. PubMed ID: 16944184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLG5 variants contribute to Crohn disease risk in a Canadian population.
    Newman WG; Gu X; Wintle RF; Liu X; van Oene M; Amos CI; Siminovitch KA
    Hum Mutat; 2006 Apr; 27(4):353-8. PubMed ID: 16450402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of DLG5 R30Q variant with inflammatory bowel disease.
    Daly MJ; Pearce AV; Farwell L; Fisher SA; Latiano A; Prescott NJ; Forbes A; Mansfield J; Sanderson J; Langelier D; Cohen A; Bitton A; Wild G; Lewis CM; Annese V; Mathew CG; Rioux JD
    Eur J Hum Genet; 2005 Jul; 13(7):835-9. PubMed ID: 15841097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of DLG5 variants with inflammatory bowel disease in the New Zealand Caucasian population and meta-analysis of the DLG5 R30Q variant.
    Browning BL; Huebner C; Petermann I; Demmers P; McCulloch A; Gearry RB; Barclay ML; Shelling AN; Ferguson LR
    Inflamm Bowel Dis; 2007 Sep; 13(9):1069-76. PubMed ID: 17455201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations.
    Medici V; Mascheretti S; Croucher PJ; Stoll M; Hampe J; Grebe J; Sturniolo GC; Solberg C; Jahnsen J; Moum B; Schreiber S; Vatn MH
    Eur J Hum Genet; 2006 Apr; 14(4):459-68. PubMed ID: 16493449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association of DLG5 R30Q with familial and sporadic inflammatory bowel disease in men.
    Lin Z; Poritz L; Franke A; Li TY; Ruether A; Byrnes KA; Wang Y; Gebhard AW; MacNeill C; Thomas NJ; Wu R; Schreiber S; Koltun WA
    Dis Markers; 2009; 27(5):193-201. PubMed ID: 20037206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of DLG5 and inflammatory bowel disease across populations.
    Tenesa A; Noble C; Satsangi J; Dunlop M
    Eur J Hum Genet; 2006 Mar; 14(3):259-60; author reply 260-1. PubMed ID: 16391570
    [No Abstract]   [Full Text] [Related]  

  • 13. Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel disease.
    Li Y; Chen P; Sun J; Huang J; Tie H; Li L; Li H; Ren G
    Sci Rep; 2016 Sep; 6():33550. PubMed ID: 27633114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of the DLG5 113A variant in early-onset inflammatory bowel disease.
    Russell RK; Drummond HE; Nimmo ER; Anderson N; Wilson DC; Gillett PM; McGrogan P; Hassan K; Weaver LT; Bisset WM; Mahdi G; Satsangi J
    J Pediatr; 2007 Mar; 150(3):268-73. PubMed ID: 17307543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease.
    Lakatos PL; Fischer S; Claes K; Kovacs A; Molnar T; Altorjay I; Demeter P; Tulassay Z; Palatka K; Papp M; Rutgeerts P; Szalay F; Papp J; Vermeire S; Lakatos L;
    Inflamm Bowel Dis; 2006 May; 12(5):362-8. PubMed ID: 16670524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of DLG5 variants with gluten-sensitive enteropathy.
    Festen EA; Zhernakova A; Wijmenga C; Weersma RK
    Gut; 2008 Jul; 57(7):1027-8. PubMed ID: 18559397
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus.
    De Jager PL; Graham R; Farwell L; Sawcer S; Richardson A; Behrens TW; Compston A; Hafler DA; Kere J; Vyse TJ; Rioux JD
    Genes Immun; 2006 Jun; 7(4):327-34. PubMed ID: 16642031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication of an association between IL23R gene polymorphism with inflammatory bowel disease.
    Oliver J; Rueda B; López-Nevot MA; Gómez-García M; Martín J
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):977-81, 981.e1-2. PubMed ID: 17678845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
    Glas J; Stallhofer J; Ripke S; Wetzke M; Pfennig S; Klein W; Epplen JT; Griga T; Schiemann U; Lacher M; Koletzko S; Folwaczny M; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1737-44. PubMed ID: 19455118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DLG5 variants and susceptibility to inflammatory bowel disease in the Scottish population.
    Browning BL
    Gut; 2006 Jul; 55(7):1050; author reply 1050. PubMed ID: 16766759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.